BTAIVSPRME• 6 Months (Normalized)
BTAI vs PRME (BioXcel Therapeutics Inc. vs Prime Medicine Inc.)
Showing Closing Date Range from Mar, 19 to Sep, 15, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.04
-97.21%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
PRME Performance $3.14
-14.67%
Prime Medicine Inc.
Normalized Baseline0.00%
Alpha Spread Margin PRME LEADS
-82.54%
PRME outperforming by 82.54%
BTAIPRME
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI PRME
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | BTAI Price | BTAI Gain (%) | PRME Price | PRME Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 15, 2026 | $0.04 | -97.21% | $3.14 | -14.67% | -82.54% |
| Sep 14, 2026 | $0.05 | -97.18% | $3.18 | -13.59% | -83.59% |
| Sep 11, 2026 | $0.05 | -96.81% | $3.13 | -14.95% | -81.86% |
| Sep 10, 2026 | $0.05 | -96.88% | $3.35 | -8.97% | -87.91% |
| Sep 09, 2026 | $0.05 | -97.06% | $3.47 | -5.71% | -91.35% |
| Sep 08, 2026 | $0.04 | -97.31% | $3.56 | -3.26% | -94.05% |
| Sep 04, 2026 | $0.07 | -95.38% | $3.70 | +0.54% | -95.92% |
| Sep 03, 2026 | $0.12 | -92.63% | $3.71 | +0.82% | -93.45% |
| Sep 02, 2026 | $0.11 | -93.31% | $3.67 | -0.27% | -93.04% |
| Sep 01, 2026 | $0.14 | -91.44% | $3.57 | -2.99% | -88.45% |
| Aug 31, 2026 | $0.16 | -89.81% | $3.59 | -2.45% | -87.36% |
| Aug 28, 2026 | $0.18 | -88.69% | $3.61 | -1.90% | -86.79% |
| Aug 27, 2026 | $0.72 | -55.06% | $3.64 | -1.09% | -53.97% |
| Aug 26, 2026 | $0.78 | -51.25% | $3.58 | -2.72% | -48.53% |
| Aug 25, 2026 | $0.74 | -53.63% | $3.71 | +0.82% | -54.45% |
Page 1 of 9